Ryosuke Ono

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of danuglipron ( <scp>PF</scp> ‐06882961), an oral small‐molecule glucagon‐like peptide‐1 receptor agonist, in Japanese adults with type 2 diabetes mellitus

Ryosuke Ono, Kenichi Furihata, Yoshihiko Ichikawa et al. · Diabetes Obesity and Metabolism · 2022 · 33 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis

Ryosuke Ono, Michio Yagi, Akinobu Shôji et al. · The Journal of Dermatology · 2019 · 16 citations

Medicine, Dermatology, Pharmacology +15

A Comparison of the Pharmacokinetics and Drug Safety Among East Asian Populations

Masayo Oishi, Shintaro Hiro, Nobushige Matsuoka et al. · Therapeutic Innovation & Regulatory Science · 2014 · 13 citations

Pharmacy, Pharmacokinetics, Pharmacology +12